MDXG - MiMedx Group, Inc.
NEXT EARNINGS:
Feb 25, 2026
(today)
EPS Est: $0.09
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$10.00
DETAILS
HIGH:
$10.00
LOW:
$10.00
MEDIAN:
$10.00
CONSENSUS:
$10.00
UPSIDE:
86.92%
Market Cap:
792.35M
Volume:
572,249
Avg Volume:
879,578
52 Week Range:
4.89-8.46
Sector:
Healthcare
Industry:
Biotechnology
Beta:
1.59
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
837
IPO Date:
2008-02-12
EPS (TTM):
0.29
P/E Ratio:
33.33
Revenue (TTM):
348.88M
Total Assets:
263.92M
Total Debt:
24.84M
Cash & Equiv:
104.42M
Rev Growth (5Y):
3.1%
EPS Growth (5Y):
0.4%
FCF Growth (5Y):
20.4%
ROCE:
27.2%
Debt/Equity:
0.13
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-10-29 | $0.15 | $0.07 | +114.3% | $113.7M | $106.9M | +6.4% |
| 2025-07-30 | $0.10 | $0.06 | +66.7% | $98.6M | $93.3M | +5.7% |
| 2025-04-30 | $0.06 | $0.06 | 0.0% | $88.2M | $86.3M | +2.2% |
| 2025-02-26 | $0.07 | $0.07 | 0.0% | $92.9M | $89.4M | +3.9% |
| 2024-10-30 | $0.05 | $0.04 | +13.6% | $84.1M | $89.4M | -6.0% |
| 2024-07-31 | $0.08 | $0.08 | 0.0% | $87.2M | $88.9M | -1.9% |
| 2024-04-30 | $0.07 | $0.05 | +40.0% | $84.7M | $79.4M | +6.7% |
| 2024-02-28 | $0.04 | $0.08 | -50.0% | $86.8M | $85.0M | +2.1% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 348.88M | 321.48M | 267.84M | 242.02M | 248.23M | 299.25M | 359.11M | 321.14M | 245.01M | 187.30M | 118.22M | 59.18M |
| Net Income | 42.42M | 67.44M | (30.20M) | (12.30M) | (49.28M) | (25.58M) | (29.98M) | 64.73M | 11.97M | 29.45M | 6.22M | (4.11M) |
| EPS | 0.29 | 0.48 | -0.27 | -0.09 | -0.46 | -0.24 | -0.28 | 0.61 | 0.00 | 0.28 | 0.06 | -0.04 |
| Total Assets | 263.92M | 239.05M | 171.43M | 187.93M | 202.03M | 167.17M | 122.84M | 121.25M | 193.26M | 135.91M | 109.26M | 84.69M |
| Total Debt | 24.84M | 48.10M | 52.47M | 53.29M | 51.83M | 69.74M | 229,000 | 286,000 | 31,000 | 133,000 | 0 | 0 |
| Cash & Equivalents | 104.42M | 82.00M | 65.95M | 87.08M | 95.81M | 69.07M | 45.12M | 27.48M | 34.39M | 28.49M | 46.58M | 44.08M |
| Operating Cash Flow | 66.20M | 26.77M | (17.89M) | (1.98M) | (30.26M) | (39.41M) | 35.80M | 62.94M | 25.83M | 18.81M | 16.80M | (285,477) |
| Free Cash Flow | 64.52M | 24.79M | (19.41M) | (5.20M) | (34.49M) | (41.63M) | 25.77M | 57.54M | 18.72M | 12.13M | 13.65M | (3.31M) |
| FCF per Share | 0.44 | 0.21 | -0.17 | -0.05 | -0.32 | -0.39 | 0.24 | 0.54 | 0.18 | 0.11 | 0.13 | -0.03 |
| Book Value | 193.11M | 142.72M | 74.51M | 92.58M | 91.42M | 34.40M | 49.66M | 73.80M | 133.00M | 107.99M | 89.33M | 73.57M |
| Cash & ST Investments | 104.42M | 82.00M | 65.95M | 87.08M | 95.81M | 69.07M | 45.12M | 27.48M | 34.39M | 31.49M | 52.33M | 44.08M |
| ROC Equity | 0.22 | 0.47 | -0.41 | -0.13 | -0.54 | -0.74 | -0.60 | 0.88 | 0.09 | 0.27 | 0.07 | -0.06 |